Hemispherx Biopharma (HEB) Continues To Rip Higher On "Most Promising Mucosal Adjuvant for Influenza" Publication
Tweet Send to a Friend
After jumping 47% yesterday, shares of Hemispherx Biopharma, Inc. (AMEX: HEB) are up another 17% this AM. Traders are reacting ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
